There is a growing effort to standardize the evaluation and management of pediatric SSRDs, which have been reported as the second most common reason for consultation after suicide assessments.
Laura Andersen, MD, MPH
Advertisement
Articles by Laura Andersen, MD, MPH
Clinicians, families, and patients all report frustration with SSRD treatment in hospitals. It’s time to improve it.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive FDA Meeting for Abuse Deterrent Fentanyl Patch
2
Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD
3
“Porosity”: Connecting 2 Western Cultural Psychiatric Discourses in Tokyo by Way of Naples
4
Candy and Other Food Treats or Tricks
5
